Speakers & Experts
Speakers & Experts include leading VCs and corporates, investors, international business executives, prestigious experts in their field, who will share their expertise in the various plenary and discussion sessions
Speakers, Moderators and Panellists:
Holger Bengs
Biotech Consulting
(Germany)
Siegfried Bialojan
Industry Leader Health Sciences Germany
Ernst & Young Germany
(Germany)
Annegret de Baey
TVM Capital
(Germany)
Niels Emmerich
Managing Director, Chief Operating Officer, Co-Founder
Immatics biotechnologies
(Germany)
Hanns Frohnmeyer
Team leader Life Science
Landesbank Baden-Württemberg (LBBW)
(Germany)
Regine Hagen-Eck
CMS Hasche Sigle
(Germany)
George J.M. Hersbach
President & Chief Executive Officer
Heartstream Group B.V.
(Netherlands)
Ingmar Hoerr
CEO
CureVac GmbH
(Germany)
Michael Kendon
Korral Partners Limited
(United Kingdom)
Ralf Kindervater
BIOPRO Baden-Württemberg GmbH
(Germany)
Claus Kremoser
PheneX Pharmaceuticals AG
(Germany)
Jason Loveridge
ARTHRO KINETICS PLC
(Germany)
Seppo Makinen
BioFund
(Finland)
George Morris
Valirx Plc
(United Kingdom)
Jörg Neermann
Life Sciences Partners
(Netherlands)
Tibor Papp
Head of Consultancy
PharmaVentures
(United Kingdom)
Douglas Pretsell
Account Director
College Hill Life Sciences
(Germany)
Andy Sandham
Venture Partner
Abingworth LLP
(United Kingdom)
Jesse Schulman
Director Analysis & Research
Ferghana Partners Group
(United Kingdom)
Karim Serrar
Strategic Advisor
Europe Unlimited
(Belgium)
Claire Skentelbery
Director of Operations
Europe Unlimited
(Belgium)
Ulrich Springer
CMS Hasche Sigle
(Germany)
Roland Toder
Vivendy Therapeutics Ltd.
(Switzerland)
Mark Treherne
NeuroDiscovery
(United Kingdom)
Johan Vanhemelrijck
Secretary General
EuropaBio
(Belgium)
Joachim Wekerle
Head of the Life Sciences Division
Baden-Württemberg Ministry of Economy
(Germany)
Rainer Wessel
GANYMED Pharmaceuticals
(Germany)
Olaf Wilhelm
Wilex AG
(Germany)
Jan Zur Hausen
Sal Oppenheim & Cie. KGaA
(Germany)
Experts:
Ivica Cerina
NGN Capital
(Germany)
Richard F. Chambers
BioConnect AG
(Germany)
Steven Dickman
CBT Advisors
(United States)
Viktor Drvota
Life Sciences
SEB Venture Capital
(Sweden)
Björn Ehring
quirin bank
(Germany)
Marion Jung
Principal
Earlybird Venture Capital
(Germany)
Arnd Kaltofen
Life Sciences
VI Partners AG
(Switzerland)
Marcel Kloosterman
DSM Venturing / Chemelot Ventures
(Netherlands)
Andrew Mackie
Head of Life Sciences
IP Group
(United Kingdom)
George Morris
Valirx Plc
(United Kingdom)
Frank Mühlenbeck
aeris Capital AG
(Switzerland)
Simon Nebel
Managing Partner
Aravis SA
(Switzerland)
Jörg Neermann
Life Sciences Partners
(Netherlands)
Heiko Ott
Investment Manager
BayTech Venture Capital GmbH
(Germany)
Marc Perret
Senior Partner
Gilde Healthcare Partners
(Netherlands)
Manfred Peter
Head of Life Science Group
LBBW Venture Capital GmbH
(Germany)
Harald Poth
LBBW Venture Capital GmbH
(Germany)
Gerhard Ries
BioMedPartners AG
(Switzerland)
Andy Sandham
Venture Partner
Abingworth LLP
(United Kingdom)
Christian Sarwa
NBGI Ventures
(United Kingdom)
Jesse Schulman
Director Analysis & Research
Ferghana Partners Group
(United Kingdom)
Jens Sundbye
European Federation of Biotechnology (EFB)
(Denmark)
Thomas Tscherning
& Director
BankInvest Group
(Denmark)
Bert van Toor
Founding Partner
Vesalius Biocapital Partners
(Luxembourg)
Werner Wolf
Venture Partner and Senior Science & Technology Advisor
TVM Capital
(Germany)
